|
Market Closed -
Nasdaq
06:00:00 03/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 135.07 USD | -0.01% |
|
0.00% | +78.95% |
| 03/09 | AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics | MT |
| 03/09 | Apogee Therapeutics, Inc.(NasdaqGM:APGE) dropped from S&P Biotechnology Select Industry Index | CI |
| Market Cap | 10.19B 8.83B 8.33B 7.56B 14.18B 976B 14.28B 99.48B 38.33B 495B 38.26B 37.42B 1,575B | P/E 2026 * |
-31.4x | P/E 2027 * | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 9.22B 7.99B 7.54B 6.84B 12.84B 884B 12.93B 90.09B 34.71B 449B 34.65B 33.88B 1,426B | EV / Sales 2026 * |
553x | EV / Sales 2027 * | 1,135x |
| Free-Float |
97.31% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| APGE | Delayed | |
CBOE
| APGE | Real-time |
Last Transcript: APOE THERPAR
| 1 day | -0.01% | ||
| Current month | -0.01% | ||
| 1 month | +0.39% | ||
| 3 months | +52.92% | ||
| 6 months | +87.86% | ||
| Current year | +78.95% |
| 1 month | 134.51 |  | 135.09 |
| Current year | 60.35 | | 135.09 |
| 1 year | 35.39 | | 135.09 |
| 3 years | 14.19 | | 135.09 |
| 5 years | 14.19 | | 135.09 |
| 10 years | 14.19 | | 135.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jane Henderson
DFI | Director of Finance/CFO | 60 | 01/01/2023 |
Tim Piringer
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2023 |
Carl Dambkowski
CTO | Chief Tech/Sci/R&D Officer | 41 | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Fairmount Funds Management LLC
| Issuer sale | Company | -340,855 | 0.5480% | |
| 3/9/26 | Issuer sale | Director | -48,780 | 0.0784% | ||
| 3/9/26 | Venrock Associates
| Issuer sale | Company | -2,115,853 | 3.4016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.01% | 0.00% | +266.24% | +549.69% | 10.19B | |
| +0.56% | -4.71% | -2.45% | +9.18% | 45.63B | |
| +0.66% | -2.34% | +340.62% | +530.14% | 43.96B | |
| +1.49% | -0.78% | +41.90% | +24.75% | 43.73B | |
| +2.11% | -1.24% | +9.09% | +78.25% | 40.23B | |
| +0.34% | -4.03% | +9.34% | +38.90% | 31.86B | |
| +0.53% | -2.08% | - | - | 17.4B | |
| +1.34% | +0.70% | +21.35% | +112.62% | 16.62B | |
| +2.07% | +0.78% | +13.07% | +30.91% | 14.46B | |
| -1.85% | -5.33% | +78.63% | +31.45% | 13.04B | |
| Average | +0.72% | -1.55% | +86.42% | +156.21% | 27.71B | |
| Weighted average by Cap. | +0.91% | -1.93% | +83.32% | +144.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.67M 14.44M 13.63M 12.36M 23.19M 1.6B 23.36M 163M 62.72M 810M 62.6M 61.22M 2.58B | 8.33M 7.22M 6.81M 6.18M 11.6M 799M 11.68M 81.38M 31.36M 405M 31.3M 30.61M 1.29B |
| Net income | -311M -270M -254M -231M -433M -29.82B -436M -3.04B -1.17B -15.13B -1.17B -1.14B -48.1B | -372M -322M -304M -276M -518M -35.66B -522M -3.63B -1.4B -18.09B -1.4B -1.37B -57.52B |
| Net Debt | -962M -833M -786M -713M -1.34B -92.16B -1.35B -9.39B -3.62B -46.75B -3.61B -3.53B -149B | -731M -634M -598M -542M -1.02B -70.09B -1.02B -7.14B -2.75B -35.55B -2.75B -2.69B -113B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- APGE Stock
Select your edition
All financial news and data tailored to specific country editions
